* * * Read the Oxford Statement developed and signed by the conference delegates ***

* * *See the photos, the presentations (The presentations are available to the conference attendees only. A password was sent by email),
the attendee list, and artist drawings are available for the delegates. For more information, please contact mqph2018@ndm.ox.ac.uk ***

The first-ever dedicated academic conference on Medicine Quality & Public Health took place in Oxford, United Kingdom, from 23 – 28 September 2018.

It brought together people from a diversity of sectors working in this field, such as public health, national regulatory authorities, pharmacy, biomedical, chemistry, law, ethics, cultural and social sciences, the pharmaceutical industry, international organisations, NGOs, national procurement centres, and internet and pharmaceutical forensics. The Oxford statement was released shortly after the conference – read more here. A fuller statement will be published in the new year.

Please see photos. Presentations, the attendee list, and the artist drawings will be available soon for the attendees. 

Any enquiries, please contact mqph2018@ndm.ox.ac.uk 


Tweet us using #MQPH2018

Bringing together people from sectors such as:

  • Public health

  • National regulatory authorities

  • Pharmacies

  • Internet

  • Biomedical

  • Chemistry

  • Law

  • Pharmaceutical forensics

  • Ethics

  • Cultural and social sciences

  • Pharmaceutical industries

  • International organisations

  • NGOs

  • National procurement centres


Latest conference programme

                        Opening speakers

Agnes Sitta Kijo
Agnes Sitta Kijo Acting Director General, Tanzania Food and Drugs Authority (TFDA)
Agnes Sitta Kijo is the Acting Director General, Tanzania Food and Drugs Authority (TFDA). Trained as a Pharmacist in Chennai, India, she has a MSc in Pharmaceutical Technology from Kings College, London. She has worked for 18 years in regulatory affairs and is currently Chair of the Pan African Harmonization Working Party (PAHW), of regulators aiming to improve access to safe and affordable medical devices and diagnostics in Africa though harmonized regulation.
Professor Louise Richardson AAS ACSS FRSE RIIA
Professor Louise Richardson AAS ACSS FRSE RIIAVice-Chancellor of the University of Oxford
Professor Louise Richardson is Vice-Chancellor of the University of Oxford. A political scientist by training, she was previously the Principal and Vice-Chancellor of the University of St Andrews, and also spent 20 years on the faculty of Harvard University, latterly as Executive Dean of the Radcliffe Institute for Advanced Study.
Professor Mojisola Christianah Adeyeye
Professor Mojisola Christianah AdeyeyeDirector General of National Agency for Food & Drug Administration and Control
Prof Mojisola Christianah Adeyeye was appointed the Director General of National Agency for Food & Drug Administration and Control (NAFDAC) the regulatory agency of Nigeria in November 2017. She currently serves as the Chair of the Steering Committee of the African Medicines Regulatory Harmonization (AMRH). She is Professor Emeritus of Pharmaceutics and Drug Product Evaluation and a Fellow of Nigeria Academy of Science
Dr Suzanne Hill
Dr Suzanne HillDirector of Essential Medicines and Health Products Department, World Health Organization
Dr Suzanne Hill, the Director of the Essential Medicines and Health Products Department of the World Health Organization, is a clinical pharmacologist and public health physician, trained at the University of Newcastle, Australia. Prior to this appointment, she was Chair of the Australian Pharmaceutical Benefits Committee from September 2011-March 2015, as well as Visiting Professor at the University of Melbourne Medical School.
Professor Sir Nicholas White OBE FRS
Professor Sir Nicholas White OBE FRSProfessor of Tropical Medicine at Oxford University and Mahidol University, Thailand
Professor Sir Nick has played a key role in ensuring the global recommendation of artemisinin-based combination therapy (ACT) as the most effective treatment for falciparum malaria. His research and advocacy work have transformed the treatment approaches used to prevent and cure millions of patients from malaria-endemic countries in Africa and Southeast Asia.

Conference location in Oxford

Oxford is located in central southern England, revolving around its University that was established in the 12th century. The architecture of the University’s colleges in the city’s medieval centre led poet Matthew Arnold to nickname it the ‘City of Dreaming Spires’.

Tourist information can be found via Experience Oxfordshire.

The conference was held in Keble College, OX1 3PG. The College was founded in 1870 and is one of the largest of the 38 Oxford colleges.

More information is available via the Keble College website